BVF INVESTMENTS LLC
CIK 1132245 · last filed 2015-11-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.08B
Companies
10
Total Filings
24
Lifetime Open-Market Net
$163.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CCXI | 2,744,577 | $14.52 | $39.85M | -$50.09M | 3 | 2015-11-02 | |
| CBIO | 16,323 | $16.44 | $268.4K | $0 | 1 | 2015-08-21 | |
| LGND | 248,144 | $296.28 | $73.52M | $7.41M | 3 | 2014-03-26 | |
| RIGL | 112,385 | $38.50 | $4.33M | -$7.68M | 1 | 2013-11-20 | |
| Celera CORP (CRA) Delisted | 34,656,684 | — | — | $204.30M | 2 | 2011-05-12 | |
| NBIX | 10,257,894 | $182.83 | $1.88B | -$2.39M | 3 | 2010-04-13 | |
| FACT | 7,671,129 | $10.67 | $81.85M | $40.31M | 2 | 2010-02-04 | |
| NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (NTII) Delisted | 4,133,897 | — | — | -$25.15M | 1 | 2009-10-23 | |
| AVIGEN INC \DE (AVGN) Delisted | 15,952,630 | — | — | -$3.03M | 3 | 2009-10-23 | |
| EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | 8,404,399 | — | — | $56.2K | 2 | 2008-11-26 |
Recent Filings · Page 2 of 3
24 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-04-13 | NBIX | Sell (S) | −1,188,000 | -$3.30M | EDGAR |
| 2010-04-02 | — | Sell (S) | −22,518,000 | -$137.66M | |
| 2010-02-04 | FACT | Buy (P) | +940,494 | $14.74M | EDGAR |
| 2010-01-29 | FACT | Buy (P) | +1,629,600 | $25.57M | EDGAR |
| 2009-10-23 | NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (NTII) Delisted | Sell (S) | −27,638,370 | -$25.15M | EDGAR |
| 2009-10-23 | AVIGEN INC \DE (AVGN) Delisted | Sell (S) | −2,833,200 | -$4.25M | EDGAR |
| 2009-10-20 | — | Sell (S) | −3,830,400 | -$90.38M | |
| 2009-01-26 | NBIX | Buy (P) | +79,500 | $246.3K | EDGAR |
| 2008-11-26 | EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted | Buy (P) | +61,500 | $28.8K | EDGAR |
| 2008-11-26 | NBIX | Buy (P) | +272,000 | $666.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.